Dr Ana Maria Ortega-Prieto is a Research Associate in the Department of Infectious Diseases at King’s College London (KCL) After obtaining a degree in Biology (Universidad de Málaga, 2008) and an MSc in Molecular and Cellular Biology (Universidad Autonoma de Madrid, 2010), Dr Ortega-Prieto joined the CBMSO-CSIC in Madrid, Spain, to carry out a PhD thesis, where her research was aimed at the characterisation of antiviral agents that act through lethal mutagenesis against HCV. In 2015, she joined Marcus Dorner's lab at Imperial College London as a Postdoctoral Fellow to develop more complex and physiological in vitro and in vivo model systems to evaluate immunological responses and treatment strategies against several human pathogens, including HCV, HBV, HIV, ZIKV and malaria. To further complement her knowledge about human pathogens, Dr Ortega-Prieto joined Professor Michael Malim’s lab at KCL in 2020 to study HIV, Influenza virus, and SARS-CoV-2 host interactions.